Expert symposium: Paracetamol first-line for paediatric use

November 07, 1999

November 8, 1999 - Paracetamol is the first-line choice for the treatment of pain and fever in children, according to a leading Australian paediatrician.

Speaking at the 'Clinical Consensus - An International Update on Paracetamol' symposium held today in Sydney, Australia, Dr Noel Cranswick, Consultant Clinical Pharmacologist and Consultant Paediatrician, Royal Children's Hospital, Melbourne, told international delegates that paracetamol in the recommended doses has few side effects and is remarkably well tolerated by children.

Dr Cranswick explained that paracetamol has a 40 year safety record. He used the presentation as an opportunity to put the use of paracetamol into context with other medications: "Paracetamol is clearly the first-line over-the-counter medication for the management of paediatric fever and pain. Aspirin is no longer an appropriate alternative in children, where there is a risk of Reye's Syndrome."

Professor Richard Day, Director of Clinical Pharmacology and Toxicology, St Vincent's Hospital, Sydney, Australia, agreed that it was appropriate that paracetamol maintained its first-line status in paediatric use.

"Ibuprofen might be suitable in some specific circumstances but given the efficacy and safety profile of paracetamol and its long history of use, I would certainly see paracetamol as first line," said Professor Day.
-end-
Press contact:
Claire Powell
MediTech Media
Tel: 44-0-171-404-7151 ext 172
Fax: 44-0-171-404-6946
email: ClaireP@MediTech.co.uk

MediTech Media Ltd.

Related Pain Articles from Brightsurf:

Pain researchers get a common language to describe pain
Pain researchers around the world have agreed to classify pain in the mouth, jaw and face according to the same system.

It's not just a pain in the head -- facial pain can be a symptom of headaches too
A new study finds that up to 10% of people with headaches also have facial pain.

New opioid speeds up recovery without increasing pain sensitivity or risk of chronic pain
A new type of non-addictive opioid developed by researchers at Tulane University and the Southeast Louisiana Veterans Health Care System accelerates recovery time from pain compared to morphine without increasing pain sensitivity, according to a new study published in the Journal of Neuroinflammation.

The insular cortex processes pain and drives learning from pain
Neuroscientists at EPFL have discovered an area of the brain, the insular cortex, that processes painful experiences and thereby drives learning from aversive events.

Pain, pain go away: new tools improve students' experience of school-based vaccines
Researchers at the University of Toronto and The Hospital for Sick Children (SickKids) have teamed up with educators, public health practitioners and grade seven students in Ontario to develop and implement a new approach to delivering school-based vaccines that improves student experience.

Pain sensitization increases risk of persistent knee pain
Becoming more sensitive to pain, or pain sensitization, is an important risk factor for developing persistent knee pain in osteoarthritis (OA), according to a new study by researchers from the Université de Montréal (UdeM) School of Rehabilitation and Hôpital Maisonneuve Rosemont Research Centre (CRHMR) in collaboration with researchers at Boston University School of Medicine (BUSM).

Becoming more sensitive to pain increases the risk of knee pain not going away
A new study by researchers in Montreal and Boston looks at the role that pain plays in osteoarthritis, a disease that affects over 300 million adults worldwide.

Pain disruption therapy treats source of chronic back pain
People with treatment-resistant back pain may get significant and lasting relief with dorsal root ganglion (DRG) stimulation therapy, an innovative treatment that short-circuits pain, suggests a study presented at the ANESTHESIOLOGY® 2018 annual meeting.

Sugar pills relieve pain for chronic pain patients
Someday doctors may prescribe sugar pills for certain chronic pain patients based on their brain anatomy and psychology.

Peripheral nerve block provides some with long-lasting pain relief for severe facial pain
A new study has shown that use of peripheral nerve blocks in the treatment of Trigeminal Neuralgia (TGN) may produce long-term pain relief.

Read More: Pain News and Pain Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.